128 related articles for article (PubMed ID: 36702290)
21. Inhibin B suppresses anoikis resistance and migration through the transforming growth factor-β signaling pathway in nasopharyngeal carcinoma.
Zou G; Ren B; Liu Y; Fu Y; Chen P; Li X; Luo S; He J; Gao G; Zeng Z; Xiong W; Li G; Huang Y; Xu K; Zhang W
Cancer Sci; 2018 Nov; 109(11):3416-3427. PubMed ID: 30151927
[TBL] [Abstract][Full Text] [Related]
22. GSTM3 enhances radiosensitivity of nasopharyngeal carcinoma by promoting radiation-induced ferroptosis through USP14/FASN axis and GPX4.
Chen Y; Feng Y; Lin Y; Zhou X; Wang L; Zhou Y; Lin K; Cai L
Br J Cancer; 2024 Mar; 130(5):755-768. PubMed ID: 38228715
[TBL] [Abstract][Full Text] [Related]
23. TIPE3 hypermethylation correlates with worse prognosis and promotes tumor progression in nasopharyngeal carcinoma.
Ren XY; Wen X; Li YQ; Zhang J; He QM; Yang XJ; Tang XR; Wang YQ; Zhang PP; Chen XZ; Cheng B; Ma J; Liu N
J Exp Clin Cancer Res; 2018 Sep; 37(1):227. PubMed ID: 30217224
[TBL] [Abstract][Full Text] [Related]
24.
Sato K; Sano D; Takahashi H; Kuwahara T; Aizawa Y; Aoyama J; Nojima Y; Hatano T; Arai Y; Nishimura G; Hatakeyama H; Oridate N
Anticancer Res; 2023 Jun; 43(6):2571-2582. PubMed ID: 37247900
[TBL] [Abstract][Full Text] [Related]
25. YPEL3 suppresses epithelial-mesenchymal transition and metastasis of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway.
Zhang J; Wen X; Ren XY; Li YQ; Tang XR; Wang YQ; He QM; Yang XJ; Sun Y; Liu N; Ma J
J Exp Clin Cancer Res; 2016 Jul; 35(1):109. PubMed ID: 27400785
[TBL] [Abstract][Full Text] [Related]
26. Reducing NETO2 expression prevents human nasopharyngeal carcinoma (NPC) progression by suppressing metastasis and inducing apoptosis.
He AR; Zhu Q; Gao S
Biochem Biophys Res Commun; 2019 May; 513(2):494-501. PubMed ID: 30975469
[TBL] [Abstract][Full Text] [Related]
27. FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway.
Chen CH; Shiu LY; Su LJ; Huang CY; Huang SC; Huang CC; Yin YF; Wang WS; Tsai HT; Fang FM; Chuang WC; Kang HC; Hwang CF
J Transl Med; 2012 May; 10():93. PubMed ID: 22591637
[TBL] [Abstract][Full Text] [Related]
28. Liraglutide protects high-glucose-stimulated fibroblasts by activating the CD36-JNK-AP1 pathway to downregulate P4HA1.
Zhao T; Chen H; Cheng C; Zhang J; Yan Z; Kuang J; Kong F; Li C; Lu Q
Biomed Pharmacother; 2019 Oct; 118():109224. PubMed ID: 31349139
[TBL] [Abstract][Full Text] [Related]
29. Identification of P4HA1 as a prognostic biomarker for high-grade gliomas.
Hu WM; Zhang J; Sun SX; Xi SY; Chen ZJ; Jiang XB; Lin FH; Chen ZH; Chen YS; Wang J; Yang QY; Guo CC; Mou YG; Chen ZP; Zeng J; Sai K
Pathol Res Pract; 2017 Nov; 213(11):1365-1369. PubMed ID: 28964577
[TBL] [Abstract][Full Text] [Related]
30. The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer.
Walsh CA; Akrap N; Garre E; Magnusson Y; Harrison H; Andersson D; Jonasson E; Rafnsdottir S; Choudhry H; Buffa F; Ragoussis J; Ståhlberg A; Harris A; Landberg G
PLoS One; 2020; 15(7):e0236187. PubMed ID: 32692762
[TBL] [Abstract][Full Text] [Related]
31. The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression.
Chakravarthi BV; Pathi SS; Goswami MT; Cieślik M; Zheng H; Nallasivam S; Arekapudi SR; Jing X; Siddiqui J; Athanikar J; Carskadon SL; Lonigro RJ; Kunju LP; Chinnaiyan AM; Palanisamy N; Varambally S
Oncotarget; 2014 Aug; 5(16):6654-69. PubMed ID: 25115393
[TBL] [Abstract][Full Text] [Related]
32. Circular RNA TGFBR2 acts as a ceRNA to suppress nasopharyngeal carcinoma progression by sponging miR-107.
Li W; Lu H; Wang H; Ning X; Liu Q; Zhang H; Liu Z; Wang J; Zhao W; Gu Y; Li H; Sun X; Hu L; Wang D
Cancer Lett; 2021 Feb; 499():301-313. PubMed ID: 33160003
[TBL] [Abstract][Full Text] [Related]
33. Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic target.
Xie P; Yang JP; Cao Y; Peng LX; Zheng LS; Sun R; Meng DF; Wang MY; Mei Y; Qiang YY; Cao L; Xiang YQ; Luo DH; Yun JP; Huang BJ; Jia LJ; Qian CN
Cell Death Dis; 2017 Jun; 8(6):e2834. PubMed ID: 28569775
[TBL] [Abstract][Full Text] [Related]
34. MiR-30e suppresses proliferation of hepatoma cells via targeting prolyl 4-hydroxylase subunit alpha-1 (P4HA1) mRNA.
Feng G; Shi H; Li J; Yang Z; Fang R; Ye L; Zhang W; Zhang X
Biochem Biophys Res Commun; 2016 Apr; 472(3):516-22. PubMed ID: 26966067
[TBL] [Abstract][Full Text] [Related]
35. CDC42-interacting protein 4 promotes metastasis of nasopharyngeal carcinoma by mediating invadopodia formation and activating EGFR signaling.
Meng DF; Xie P; Peng LX; Sun R; Luo DH; Chen QY; Lv X; Wang L; Chen MY; Mai HQ; Guo L; Guo X; Zheng LS; Cao L; Yang JP; Wang MY; Mei Y; Qiang YY; Zhang ZM; Yun JP; Huang BJ; Qian CN
J Exp Clin Cancer Res; 2017 Jan; 36(1):21. PubMed ID: 28129778
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.
Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X
J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278
[TBL] [Abstract][Full Text] [Related]
37. lncRNA CASC2/miR‑18a‑5p axis regulates the malignant potential of nasopharyngeal carcinoma by targeting RBBP8.
Miao WJ; Yuan DJ; Zhang GZ; Liu Q; Ma HM; Jin QQ
Oncol Rep; 2019 Mar; 41(3):1797-1806. PubMed ID: 30569153
[TBL] [Abstract][Full Text] [Related]
38. Antidiabetic drug metformin suppresses tumorigenesis through inhibition of mevalonate pathway enzyme HMGCS1.
Chen Y; Li M; Yang Y; Lu Y; Li X
J Biol Chem; 2022 Dec; 298(12):102678. PubMed ID: 36356901
[TBL] [Abstract][Full Text] [Related]
39. The STAT3-miR-223-TGFBR3/HMGCS1 axis modulates the progression of cervical carcinoma.
Zhang J; Jiang M; Qian L; Lin X; Song W; Gao Y; Zhou Y
Mol Oncol; 2020 Sep; 14(9):2313-2331. PubMed ID: 32491253
[TBL] [Abstract][Full Text] [Related]
40. Cisplatin suppresses proliferation, migration and invasion of nasopharyngeal carcinoma cells in vitro by repressing the Wnt/β-catenin/Endothelin-1 axis via activating B cell translocation gene 1.
Yin P; Song G; Jiang Z
Cancer Chemother Pharmacol; 2018 May; 81(5):863-872. PubMed ID: 29536130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
